LIS Technologies Appoints Dr. Neil Campbell to Advisory Board
Oak Ridge, Tennessee – February 26, 2025 – LIS Technologies Inc. (LIST), a U.S.-based developer of advanced laser technology, today announced the appointment of Dr. Neil Campbell as Chairman of its Advisory Board for Laser Innovation and Modeling. This move comes at a time of significant developments in the domestic nuclear energy sector.
“I am delighted to join LIS Technologies at this pivotal moment for the U.S. nuclear energy industry,” said Dr. Campbell. “The Company’s strong technical and leadership teams provide a solid foundation, and I look forward to contributing my expertise to help ensure timely advancement to the next phase of development and, ultimately, demonstration.”
Dr. Campbell brings extensive experience in laser technology, optics, and fluid dynamics to the company. His work spans various laser applications, including chemical, gas, and solid-state lasers. Throughout his career, he has worked with national and university laboratories, as well as industry and defense organizations.
“Neil’s addition is an important milestone for the Company, bringing on board a seasoned leader to advance our technology to the next phase.” — Jay Yu, Executive Chairman and President of LIS Technologies Inc.
His research has focused on alternative pump solutions for molecular lasers, aimed at improving performance parameters. Dr. Campbell holds eight patents, including some related to molecular lasers that were the subject of a Department of Defense research and development program. This laser technology has potential applications in medicine, energy, and extreme light science.
This appointment is particularly timely, as LIS Technologies was recently selected as one of six companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program, worth up to $3.4 billion. The company’s Condensation Repression Isotope Selective Laser Activation (CRISLA) technology is the only U.S.-origin and patented advanced laser enrichment solution. CRISLA is optimized for both LEU and High-Assay Low-Enriched Uranium (HALEU), which is crucial for the next generation of advanced nuclear reactors. This technology offers competitive capital and operational costs.
“The demand for our proprietary CRISLA technology has never been greater in the United States,” said Jay Yu, Executive Chairman and President of LIS Technologies Inc. “With Neil on board, LIST is positioned to capitalize on this growing momentum, and I’m confident his leadership will be invaluable as we continue to advance this vital technology to market.”
“It is a pleasure to welcome Dr. Campbell to the team,” said Christo Liebenberg, CEO of LIS Technologies Inc. “His laser expertise will be immensely valuable as we move toward scaling our current infrared lasers that will be used in test loop demonstrations of our CRISLA technology.”
About LIS Technologies Inc.
LIS Technologies Inc. is a U.S.-based developer of patented advanced laser technology that uses infrared lasers for isotope separation. Their Laser Isotope Separation Technology (L.I.S.T) offers significant advantages over traditional methods like gas diffusion and centrifuges. The company’s process is both energy-efficient and cost-effective. L.I.S.T is optimized for LEU for current nuclear power plants and HALEU for advanced reactors, as well as for medical and scientific research and the production of specialized materials.
LIS Technologies Inc. was selected in 2024 as one of six domestic companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program.
For more information please visit: LaserIsTech.com
For further information, please contact:
Email: info@laseristech.com
Telephone: 800-388-5492
Follow us on X Platform
Follow us on LinkedIn
Forward-Looking Statements
This press release contains “forward-looking statements”. These statements relate to future events, and involve risks and uncertainties that could impact the company’s financial and business results. These could be difficult with design, testing, cost overruns, development of competitive technology, and other factors mentioned. Readers should not rely on forward-looking statements as a predictor of actual results.
